# A Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne Patients

> **NCT06415279** · PHASE4 · COMPLETED · sponsor: **Sun Pharmaceutical Industries Limited** · enrollment: 40 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Winlevi (clascoterone) 1% cream

## Key facts

- **NCT ID:** NCT06415279
- **Lead sponsor:** Sun Pharmaceutical Industries Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-29
- **Primary completion:** 2025-02-18
- **Final completion:** 2025-02-18
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06415279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06415279, "A Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne Patients". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06415279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*